Earlier, there were reports about Pantaloon tying up with the Seattle-based coffee chain Starbucks for its India foray.
The corporate healthcare segment may replicate the success of the Indian IT sector, say experts.
Food and grocery retail chain Spinach wants to leverage on the strength of local kiranawalas for growth.
Panacea Biotec is planning to launch its organ transplantation drugs to Latin American and South East Asian markets.
Dabur Pharma, a leading player in the domestic oncology segment, is busy finalising its marketing strategies for EU, the US and Australia.
The company has lined up exclusive outlets, international brands and expansion of production capacities for exports.
The new pharma policy proposed by Chemicals Minister Ram Vilas Paswan is likely to call for a central mechanism to oversee research and development projects in the country.
It aims at slashing the average market prices from 10 to 30 per cent for low-end brands and from 30 to 60 per cent for high-end ones.
Apart from Roche's hepatitis medicine Pegasys, which received a patent in March 2005, there have been no major announcements on grant of product patents.
The UB group may introduce a format of lounge bars where it will sell multi-branded merchandise and invest nearly Rs 8-10 crore (Rs 80-100 million) in each of the stores.
Pharma Link, a joint venture of leading pharmaceutical support service provider Interpharma Asia-Pacific
Eli Lily, Sanofi Aventis, Bristol Myers approach chemicals ministry.
Pharma companies' hope to have several of their house hold remedy brands like Crocin made available through grocery shops across the country may not materialise.
All India Organisation of Chemists and Druggists, the apex body of over 500,000 chemists that manage the bulk of the Rs 50,000 crore
Retail major Shoppers' Stop, part of the K Raheja Corp, is consolidating its luxury retail business by roping in over 40 global brands and has lined up Rs 500 crore
The domestic pharmaceuticals industry has proven its mettle once again with Glenmark Pharmaceuticals announcing the receipt of euro 25 million from German drug major Merck
The corporate hospital sector of the country is all set to take away a significant share of the tertiary healthcare service business from individual private healthcare providers by 2010.
Pharmaceutical major Wockhardt is looking at foraying into Japan either through exports or by setting up a manufacturing base.
Cheap bulk drug imports from China may soon post a threat to the Rs 20,000 crore (Rs 200 billion) domestic bulk drug industry.
The proposal will help India, one of the most cost-effective location for pharmaceutical production, to increase its growing generic exports multifold in a hassle-free regulatory environment.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances